Defining and characterizing non-biological complex drugs (NBCDs) – Is size enough? The case for liposomal doxorubicin generics (‘liposomal nanosimilars’) for injection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defining and characterizing non-biological complex drugs (NBCDs) – Is size enough? The case for liposomal doxorubicin generics (‘liposomal nanosimilars’) for injection

Published:2014-06-15 Issue:2 Volume:3 Page:56-57
ISSN:2033-6403
Container-title:Generics and Biosimilars Initiative Journal
language:
Short-container-title:GaBI J

Author:

Moghimi S Moein,Farhangrazi Z Shadi

Publisher

Pro Pharma Communications International

Subject

Drug guides,Pharmacy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro physicochemical characterization of nanocarriers: a road to optimization;Nanoparticle Therapeutics;2022

2. Challenges of in vitro characterization of nonbiological complex drugs: Example of parenteral preparations with liposomal drug carriers;Arhiv za farmaciju;2019

3. Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success;Journal of Controlled Release;2018-04

4. Personalized Nanomedicine: A Revolution at the Nanoscale;Journal of Personalized Medicine;2017-10-12

5. An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome;Journal of Controlled Release;2016-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP